116444-14-5

Basic information

• Product Name: 3,4,6,7-tetra-O-benzyl-1,2-dideoxy-d-galacto-hept-1-enitol
• Synonyms: 3,4,6,7-tetra-O-benzyl-1,2-dideoxy-d-galacto-hept-1-enitol
• CAS NO: 116444-14-5
• Molecular Weight: 538.684
• Mol File: 116444-14-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3,4,6,7-tetra-O-benzyl-1,2-dideoxy-d-galacto-hept-1-enitol(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,6,7-tetra-O-benzyl-1,2-dideoxy-d-galacto-hept-1-enitol(116444-14-5)
• EPA Substance Registry System: 3,4,6,7-tetra-O-benzyl-1,2-dideoxy-d-galacto-hept-1-enitol(116444-14-5)

Safety Data

• Hazardous Substances Data: 116444-14-5(Hazardous Substances Data)

Upstream product

• 1824-93-7 methyl-β-D-galactofuranoside 
• 77874-38-5 Methyl 2,3,5,6-tetra-O-benzoyl-β-D-galactofuranoside 
• 2065-66-9 methyl-triphenylphosphonium iodide 
• 18685-21-7 methyl 2,3,5,6-tetra-O-benzyl-β-D-galactofuranoside 
• 89539-39-9 2,3,5,6-tetra-O-benzyl-α/β-D-galactofuranose 
• 19493-09-5 Methylenetriphenylphosphorane 

Downstream Products

• 116558-38-4 3,4,5,6,7-penta-O-benzyl-1,2-dideoxy-D-galacto-hept-1-enitol 
• 92517-03-8 (2R,3R,4S,5S,6S)-3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)-6-(iodomethyl)tetrahydro-2H-pyran 
• 116444-18-9 C-(2,3,5,6-tetra-O-benzyl-α-D-galactofuranosyl)iodomethane 
• 223131-29-1 dimethyl C-(2,3,5,6-tetra-O-benzyl-α-D-galactofuranosyl)methanephosphonate 

Relevant articles and documents

D-Galactofuranosylphosphonates. First Synthesis of UDP-C-D-galactofuranose

The chemical synthesis of two phosphono analogues of D-galactofuranosyl phosphate was performed. The natural phosphate seemed to be too labile to allow the chemical synthesis of UDP-Galf, these C-galactofuranosides are stable pharmacophores, and the α-phosphono analogue has been easily converted into UDP-C-Galf. UDP-C-Galf was tested as a competitive inhibitor of UDP-galactopyranose mutase and showed inhibition of Galf formation. Thus, it is of potential interest as an antimycobacterial agent; as an active molecule against Trypanosoma cruzi, the causative agent of South American trypanosomiasis (Chagas' disease), and as a stable analogue for use in UDP-galactopyranose mutase crystallization studies.